Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,306 | 31,676 | 38,485 | 35,075 | 42,454 |
| Marketable Securities | 169,314 | 187,549 | 190,202 | 214,645 | 189,019 |
| Receivables | 15,750 | 17,118 | 11,539 | 11,395 | 9,060 |
| Inventories | 23,727 | 21,722 | 20,373 | 17,323 | 15,730 |
| TOTAL | $247,986 | $267,905 | $270,026 | $286,075 | $261,915 |
| Non-Current Assets | |||||
| PPE Net | 10,160 | 8,600 | 7,385 | 6,465 | 5,515 |
| Investments And Advances | 39,865 | 45,431 | 45,328 | 31,149 | 64,004 |
| Other Non-Current Assets | 6,406 | 6,807 | 7,307 | 6,282 | 6,590 |
| TOTAL | $56,431 | $60,838 | $60,020 | $43,896 | $76,109 |
| Total Assets | $304,417 | $328,743 | $330,046 | $329,971 | $338,024 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,318 | 4,998 | 4,461 | 3,424 | 3,454 |
| Accrued Expenses | 17,329 | 22,431 | 17,605 | 13,405 | 10,565 |
| TOTAL | $23,191 | $30,924 | $25,388 | $19,489 | $16,492 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,705 | 1,557 | 1,342 | 1,141 | 949 |
| Other Non-Current Liabilities | 6,631 | 6,912 | 6,912 | 6,179 | 5,450 |
| TOTAL | $9,981 | $10,209 | $9,898 | $8,849 | $7,780 |
| Total Liabilities | $33,172 | $41,133 | $35,286 | $28,338 | $24,272 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,562 | 44,382 | 44,025 | 43,470 | 43,356 |
| Common Shares | 5 | 4 | 4 | 4 | 4 |
| Retained earnings | -391,832 | -369,937 | -356,471 | -342,262 | -325,393 |
| Other shareholders' equity | -96 | 403 | 354 | 149 | 240 |
| TOTAL | $271,245 | $287,610 | $294,760 | $301,633 | $313,752 |
| Total Liabilities And Equity | $304,417 | $328,743 | $330,046 | $329,971 | $338,024 |